These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28435450)

  • 21. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
    Ghantous Y; Bahouth Z; Abu El-Naaj I
    Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia.
    Farah CS; Shearston K; Melton PE; Fox SA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jul; 138(1):99-111. PubMed ID: 38760284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
    Schulze K; Imbeaud S; Letouzé E; Alexandrov LB; Calderaro J; Rebouissou S; Couchy G; Meiller C; Shinde J; Soysouvanh F; Calatayud AL; Pinyol R; Pelletier L; Balabaud C; Laurent A; Blanc JF; Mazzaferro V; Calvo F; Villanueva A; Nault JC; Bioulac-Sage P; Stratton MR; Llovet JM; Zucman-Rossi J
    Nat Genet; 2015 May; 47(5):505-511. PubMed ID: 25822088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes.
    Xie F; Gleue CA; Deschaine M; Dasari S; Lau JS; Sartori-Valinotti JC; Meves A; Lehman JS
    J Oral Pathol Med; 2022 Apr; 51(4):395-404. PubMed ID: 35146808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer.
    Yang SF; Huang HD; Fan WL; Jong YJ; Chen MK; Huang CN; Chuang CY; Kuo YL; Chung WH; Su SC
    Oral Oncol; 2018 Feb; 77():1-8. PubMed ID: 29362114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
    Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
    Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients with Oral Cavity Squamous Cell Carcinoma.
    Fan WL; Yang LY; Hsieh JC; Lin TC; Lu MJ; Liao CT
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.
    Nakagaki T; Tamura M; Kobashi K; Koyama R; Fukushima H; Ohashi T; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Oncotarget; 2017 Aug; 8(35):59113-59122. PubMed ID: 28938622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome sequencing reveals molecular subgroups in oral epithelial dysplasia.
    Márquez A; Mujica I; Jordan N; Baez P; Tarquinio S; Nunes J; Adorno D; Martínez B; Morales-Pison S; Fernandez-Ramires R
    Braz Oral Res; 2023; 37():e063. PubMed ID: 37341234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma.
    Cacheux W; Dangles-Marie V; Rouleau E; Lazartigues J; Girard E; Briaux A; Mariani P; Richon S; Vacher S; Buecher B; Richard-Molard M; Jeannot E; Servant N; Farkhondeh F; Mariani O; Rio-Frio T; Roman-Roman S; Mitry E; Bieche I; Lièvre A
    Oncotarget; 2018 Jan; 9(1):464-476. PubMed ID: 29416628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
    Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
    Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic profile of PTEN gene in Indian oral squamous cell carcinoma primary tumors.
    Shah S; Jajal D; Mishra G; Kalia K
    J Oral Pathol Med; 2017 Feb; 46(2):106-111. PubMed ID: 27381359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
    Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
    Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
    Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
    Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational landscape of aggressive cutaneous squamous cell carcinoma.
    Pickering CR; Zhou JH; Lee JJ; Drummond JA; Peng SA; Saade RE; Tsai KY; Curry JL; Tetzlaff MT; Lai SY; Yu J; Muzny DM; Doddapaneni H; Shinbrot E; Covington KR; Zhang J; Seth S; Caulin C; Clayman GL; El-Naggar AK; Gibbs RA; Weber RS; Myers JN; Wheeler DA; Frederick MJ
    Clin Cancer Res; 2014 Dec; 20(24):6582-92. PubMed ID: 25303977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
    Liao CT; Yang LY; Lee LY; Lin CY; Wang HM; Ng SH; Yen TC; Fan WL; Hsieh JC
    Oral Oncol; 2021 Nov; 122():105547. PubMed ID: 34700279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas.
    Liu CJ; Lin SC; Chen YJ; Chang KM; Chang KW
    Mol Carcinog; 2006 Oct; 45(10):721-31. PubMed ID: 16676365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.